Table 1.

Sequences of constructs and oligo/antibody ratios

Experiment	Construct	Sequence	Oligo:Ab ratio
Figure 1	chTNT-3/CpG1826-biotin	5′-biotin-tccatgacgttcctgacgtt-3′	3.5:1
Figures 2, 3	chTNT-3/CpG1585	5′-ggGGTCAACGTTGAgggggg-3′	8:1
Figure 2	chTNT-3/sc1585	5′-ggGGTCAAGCTTGAgggggg-3′	8:1
Figure 3	chTNT-3/CpG1826	5′-tccatgacgttcctgacgtt-3′	4.4:1
Figures 2, 4, 5	chTNT-3/CpG1826	5′-tccatgacgttcctgacgtt-3′	2.8:1
Figures 2, 4	chTNT-3/sc1826	5′-tccatgagcttcctgagctt-3′	3.5:1
Figure 4	Cetuximab/CpG1826	5′-tccatgacgttcctgacgtt-3′	4.4:1

C–G or G–C motifs are underlined. Bases in lower case have a phosphorothioate backbone, and bases in capital letters have a phosphodiester linkage